Informações: Esta não é a versão mais recente do modelo de dados. Uma visão geral da versão pode ser encontrada à esquerda em Versões. Para a versão mais recente, clique aqui.
Informações:
Falhas:
ID
101
Descrição
ODM derived from http://clinicaltrials.gov/ct2/show/study/NCT00626548?term=NCT00626548
Link
http://clinicaltrials.gov/ct2/show/study/NCT00626548?term=NCT00626548
Palavras-chave
Versões (5)
- 22/11/2011 22/11/2011 -
- 22/11/2011 22/11/2011 -
- 27/03/2014 27/03/2014 - Martin Dugas
- 13/04/2014 13/04/2014 - Julian Varghese
- 17/09/2021 17/09/2021 -
Transferido a
22 de novembro de 2011
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0 Legacy
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer (ENTHUSE M0)
Similar models
Eligibility
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Age
Item
18 Years and older
boolean
Gender
Item
Male
boolean
Prostate Cancer
Item
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has NOT spread to the other parts of the body (metastases). Patients with lymph node involvement may be eligible if specified criteria is met.
boolean
PSA
Item
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
boolean
Castration
Item
Currently receiving treatment with surgical or medical castration
boolean
Opiate
Item
Currently using opiate based pain killers for cancer related pain
boolean
Previous chemotherapy
Item
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
boolean
Heart disease
Item
Suffering from heart failure or had a myocardial infarction within last 6 months
boolean
Epilepsy
Item
A history of epilepsy or seizures
boolean
Age
Item
Age
string
C0001779 (UMLS CUI)
102518004 (SNOMED CT 2010_0731)
102518004 (SNOMED CT 2010_0731)
Gender
Item
Gender
string
Diagnosis
Item
Diagnosis
string
Cancer of prostate
Item
Prostate carcinoma
string
C0600139 (UMLS CUI)
254900004 (SNOMED CT 2010_0731)
10036921 (MedDRA 13.1)
254900004 (SNOMED CT 2010_0731)
10036921 (MedDRA 13.1)
Metastasis
Item
Metastasis
string
C0027627 (UMLS CUI)
128462008 (SNOMED CT 2010_0731)
10027449 (MedDRA 13.1)
128462008 (SNOMED CT 2010_0731)
10027449 (MedDRA 13.1)
PSA
Item
Prostate-Specific Antigen
string
Castration
Item
Castration
string
C0007347 (UMLS CUI)
275234001 (SNOMED CT 2010_0731)
275234001 (SNOMED CT 2010_0731)
Pharmaceutical Preparations
Item
Medication
string
C0013227 (UMLS CUI)
Opiate
Item
Opiates
string
Pain
Item
Pain
string
C0030193 (UMLS CUI)
22253000 (SNOMED CT 2010_0731)
10033371 (MedDRA 13.1)
MTHU029813 (LOINC Version 232)
R52 (ICD-10-CM Version 2010)
338-338.9 (ICD-9-CM Version 2011)
E11167 (CTCAE Version 4.03)
22253000 (SNOMED CT 2010_0731)
10033371 (MedDRA 13.1)
MTHU029813 (LOINC Version 232)
R52 (ICD-10-CM Version 2010)
338-338.9 (ICD-9-CM Version 2011)
E11167 (CTCAE Version 4.03)
Chemotherapy
Item
Chemotherapy
string
C0392920 (UMLS CUI)
150415003 (SNOMED CT 2010_0731)
150415003 (SNOMED CT 2010_0731)
Heart failure
Item
Heart failure
string
C0018801 (UMLS CUI)
155374007 (SNOMED CT 2010_0731)
10019279 (MedDRA 13.1)
155374007 (SNOMED CT 2010_0731)
10019279 (MedDRA 13.1)
Acute myocardial infarction
Item
Acute myocardial infarction
string
C0155626 (UMLS CUI)
57054005 (SNOMED CT 2010_0731)
10000891 (MedDRA 13.1)
I21 (ICD-10-CM Version 2010)
410 (ICD-9-CM Version 2011)
57054005 (SNOMED CT 2010_0731)
10000891 (MedDRA 13.1)
I21 (ICD-10-CM Version 2010)
410 (ICD-9-CM Version 2011)